Schedule 13G ownership disclosure

THERIVA BIOLOGICS INC

Common Stock, $0.001 par value per share · CUSIP: 87164U508

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Empery Asset Management, LP

    Shares: 953,185.00 · Class: 9.99%

  • Ryan M. Lane

    Shares: 953,185.00 · Class: 9.99%

  • Martin D. Hoe

    Shares: 953,185.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-003293
Form type
SCHEDULE 13G
Filer
Empery Asset Management, LP
CIK
CIK 1469336
Filed
Jul 31, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub